Svs Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 25-06-2024
- Paid Up Capital ₹ 4.10 M
as on 25-06-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 71.43%
(FY 2022)
- Profit 94.87%
(FY 2022)
- Ebitda 80.37%
(FY 2022)
- Net Worth -0.15%
(FY 2022)
- Total Assets -2.58%
(FY 2022)
About Svs Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.10 M, as per Ministry of Corporate Affairs (MCA) records.
Murali Ponnala, Arjula Lakshmi, and Vaishali Arjula serve as directors at the Company.
- CIN/LLPIN
U24231TG2006PTC051218
- Company No.
051218
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Sep 2006
- Date of AGM
31 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Svs Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Murali Ponnala  | Director | 22-Sep-2006 | Current |
| Arjula Lakshmi | Director | 16-Jan-2013 | Current |
| Vaishali Arjula | Director | 07-May-2009 | Current |
Financial Performance of Svs Biotech.
Svs Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 71.43% increase. The company also saw a substantial improvement in profitability, with a 94.87% increase in profit. The company's net worth dipped by a decrease of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svs Biotech?
In 2021, Svs Biotech had a promoter holding of 100.00%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Srikar Energy Private LimitedActive 12 years 11 monthsMurali Ponnala and Vaishali Arjula are mutual person
- Srishti Avenues Private LimitedActive 15 years 5 months
Murali Ponnala, Arjula Lakshmi and 1 more are mutual person
- Srijan It Services Private LimitedActive 15 years 4 months
Murali Ponnala, Arjula Lakshmi and 1 more are mutual person
- Yasaswini Industries Private LimitedActive 17 years 9 months
Arjula Lakshmi and Vaishali Arjula are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Svs Biotech?
Unlock and access historical data on people associated with Svs Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svs Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svs Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
